FKDSF (Fukuda Denshi Co) Stock Based Compensation: $0.0 Mil (TTM As of Mar. 2026)


FKDSF Fukuda Denshi Co Ltd FKDSF
83 GF Score
Price $42.55
GF Value $27.75
! 4 Warning Signs
View Full Analysis

What is Fukuda Denshi Co Stock Based Compensation?

Fukuda Denshi Co FKDSF 83 Stock Based Compensation is $0.0 Mil as of Mar. 2026. GuruFocus rates FKDSF with a GF Score™ of 83/100 and a GF Value™ of $27.75. The stock has 4 warning signs investors should review.

Fukuda Denshi Co's Stock Based Compensation for the three months ended in Mar. 2026 was $0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

Fukuda Denshi Co Stock Based Compensation Related Terms

Fukuda Denshi Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Fukuda Denshi Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fukuda Denshi Co Stock Based Compensation Chart

Fukuda Denshi Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fukuda Denshi Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FKDSF
83GF Score
Fukuda Denshi Co Ltd FKDSF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fukuda Denshi Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

What does a Stock Based Compensation of $0.0 Mil mean?
Fukuda Denshi Co (FKDSF) has a Stock Based Compensation of $0.0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Fukuda Denshi Co and its competitors.
Is Fukuda Denshi Co's Stock Based Compensation too high?
Fukuda Denshi Co's current Stock Based Compensation is $0.0 Mil. Overall, Fukuda Denshi Co has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's Stock Based Compensation compare to ABT and SYK?
Fukuda Denshi Co's Stock Based Compensation of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Fukuda Denshi Co and its competitors. Fukuda Denshi Co's current Stock Based Compensation is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Fukuda Denshi Co (FKDSF) has a current Stock Based Compensation of $0.0 Mil. The stock's GF Value™ is $27.75, compared to a current price of $42.55 — trading 53.3% above its estimated fair value. The current Stock Based Compensation is $0.0 Mil. Fukuda Denshi Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Fukuda Denshi Co (FKDSF), the current Stock Based Compensation is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?

Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued. The current stock price of $42.55 is trading 53.3% above its estimated GF Value™ of $27.75.

Key valuation signals for FKDSF:

  • Stock Based Compensation: $0.0 Mil
  • GF Value™: $27.75 vs. price of $42.55 (53.3% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fukuda Denshi Co Business Description

Other Exchanges 6960:Japan
Address 39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score

Get the complete analysis for FKDSF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.55
Price
$27.75
GF Value